June 2014 FDA Recall Soliris by Alexion Pharmaceuticals, Inc.
D-1512-2014 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Alexion Pharmaceuticals, Inc. on June 2, 2014 for the product Soliris. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1512-2014

Reason for Recall
Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
Initiated
06-02-2014
Reported
08-13-2014
Quantity
96,506 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Alexion Pharmaceuticals, Inc.
Nationwide and Puerto Rico
Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.

Batch or Lot Expiration Information

Lot# Lots: 10002-1, 00006-1, Exp 08/14; 10003A, Exp 11/14; 10004A, Exp 02/15; 10005A, 10005AR, 10007A, 10006A, Exp 07/15; and 10008A, Exp 08/15

Affected Packages Involved in this Recall